<PAGE>
+--------+
| FORM 3 | U.S. SECURITIES AND EXCHANGE COMMISSION
+--------+ WASHINGTON, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company Act of 1935 or
Section 30(f) of the Investment Company Act of 1940
--------------------------------------------------------------------------------
1. Name and Address of Reporting Person
Sulzer Medica USA Holding Co.
----------------------------------------------------------------------------
(Last) (First) (Middle)
3 East Greenway Plaza, Suite 1600
----------------------------------------------------------------------------
(Street)
Houston, Texas 77046
----------------------------------------------------------------------------
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year) 12/27/00
--------------
3. IRS or Social Security Number of Reporting Person (Voluntary)
--------------
4. Issuer Name and Ticker or Trading Symbol Capital Partners II Ltd.
------------------------------------
Liquidating Trust
----------------------------------------------------------------------------
5. Relationship of Reporting Person to Issuer (Check all applicable)
[ ] Director [ ] Officer [X] 10% Owner [ ] Other
(give title below) (specify below)
----------------------------------------------------------------------------
6. If Amendment, Date of Original (Month/Day/Year)
----------------------------
7. Individual or Joint/Group Filing (check Applicable Line)
Form filed by One Reporting Person
---
X Form filed by More than One Reporting Person
---
TABLE 1--NON-DERIVATIVE SECURITIES BENEFICIALLY OWNED
<TABLE>
<CAPTION>
--------------------------------------------------------------------------------
1. Title 2. Amount of 3. Ownership Form: 4. Nature of
of Securities Bene- Direct (D) or Indirect Bene-
Security ficially Owned Indirect (I) ficial Ownership
(Instr. 4) (Instr. 4) (Instr. 5) (Instr. 5)
--------------------------------------------------------------------------------
<S> <C> <C> <C>
--------------------------------------------------------------------------------
Trust Units 21,627 (D)
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
</TABLE>
*If the Form is filed by more than one Reporting Person, see Instruction
5(b)(v).
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.
<PAGE>
<TABLE>
<CAPTION>
------------------------------------------------------------------------------------------------------------------------------------
1. Title of Derivative 2. Date Exer- 3. Title and Amount of Securities 4. Conversion 5. Ownership 6. Nature of In-
Security (Instr. 4) cisable and Underlying Derivative Security or Form of direct Bene-
Expiration (Instr. 4) Exercise Derivative ficial
Date Price Security: Ownership
(Month/Day/ of Direct (D) (Instr. 5)
Year) Derivative or In-
---------------------------------------------------- Security direct (I)
Date Expira- Amount or (Instr. 5)
Exer- tion Title Number of
cisable Date Shares
------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C>
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------------
</TABLE>
Explanation of Responses:
**Intentional misstatements or omissions of facts constitute Federal Criminal
Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed.
If space provided is insufficient, See Instruction 6 for procedure.
/s/ David S. Wise 1/3/01
------------------------------- -----------------
**Signature of Reporting Person Date
On behalf of Sulzer Medica USA
Holding Co.
Name: David S. Wise
Title: Secretary
<PAGE>
Joint Filer Information
-----------------------
Name: Sulzer AG
IRS Number: 98-0109623
Address: Zurcherstrasse 12, P.O. Box 414, CH-8401 Winterthur, Switzerland
Designated Filer: Sulzer Medica USA Holding Co.
Date of Event Requiring Statement: 12/27/00
Ownership form: Indirect, Trust Units owned directly by Sulzer Medica USA
Holding Co.
Signature: /s/ Roman Beran 1/3/01
-------------------------------- -------------------------
On behalf of Sulzer AG Date
Name: Roman Beran
Title: Deputy Vice President and
General Counsel, Head of
Legal Department
Signature: /s/ Kurt Haegi 1/3/01
-------------------------------- -------------------------
On behalf of Sulzer AG Date
Name: Kurt Haegi
Title: Secretary General
Name: Sulzer Medica Ltd.
Address: Zurcherstrasse 12, CH-8401 Winterthur, Switzerland
Designated Filer: Sulzer Medica USA Holding Co.
Date of Event Requiring Statement: 12/27/00
Ownership form: Indirect, Trust Units owned directly by Sulzer Medica USA
Holding Co.
Signature: /s/ Andre P. Buchel 1/3/01
-------------------------------- -------------------------
On behalf of SulzerMedica Ltd. Date
Name: Andre P. Buchel
Title: Chief Executive Officer
Signature: /s/ Vanessa Oelz 1/3/01
-------------------------------- -------------------------
On behalf of Sulzer Medica Ltd. Date
Name: Vanessa Oelz
Title: Secretary General
Page 3 of 3
